Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2014-12-08 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated December 8, 2014, announcing a scientific and technological breakthrough by Global Bioenergies: the successful production of bio-sourced propylene via direct fermentation. It details the achievement, its market significance (propylene market size), and quotes a business development director. This type of announcement, focusing on a specific operational or strategic development rather than routine financial results (ER) or mandatory regulatory filings (10-K, AR), fits best under a general announcement category. Since it is not a standard earnings release, a management discussion, a capital event, or a director dealing report, it is classified as a general Regulatory Filing (RNS) as it is an official, non-standard corporate announcement. It is too detailed and specific to be a simple Report Publication Announcement (RPA) which usually just points to another document. The length (3133 chars) is moderate, but the content is a substantive news item about R&D success.
2014-12-08 French
Global Bioenergies announces break-through in direct biological production of butadiene
Regulatory Filings Classification · 99% confidence The document is a short news release dated November 26, 2014, announcing a scientific and technological breakthrough by Global Bioenergies regarding the direct biological production of butadiene. It contains key highlights, quotes from management, and contact information. It is not a comprehensive annual report (10-K), an interim report (IR), a formal earnings release (ER) focusing on financial metrics, or a proxy statement (DEF 14A/PSI). Since it is a general corporate announcement about a development (not management change, dividend, or financing), and it is distributed via DGAP (a service often used for regulatory news), it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were summarizing financial results. Given the focus is purely on R&D progress and market potential rather than period-end financials, RNS is the most appropriate general category for non-standard corporate news, although it shares characteristics with an ER in terms of being a timely announcement. However, since it is not a standard financial results announcement but a technology update, RNS serves as the best fit among the provided options for a general, non-specific corporate news item distributed via a regulatory wire service.
2014-11-26 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is titled with a headline announcing a scientific/technological breakthrough ("Global Bioenergies announces break-through in direct biological production of butadiene") and is explicitly labeled as a "PRESS RELEASE" at the end. It details a specific development, includes quotes from management, and provides contact information. This structure is characteristic of an announcement intended for the public and media, rather than a formal regulatory filing like a 10-K, IR, or a specific financial report (ER, MRQ). Since it is a general announcement about company progress and technology, and does not fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), the most appropriate general category for a press release announcing significant operational news is Regulatory Filings (RNS), which serves as a broad category for miscellaneous regulatory/public announcements that aren't covered by more specific codes.
2014-11-26 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release from Global Bioenergies dated November 26, 2014, announcing a scientific breakthrough: the successful production of bio-sourced butadiene via direct fermentation. It details a technological achievement, collaboration with Synthos, and future development plans. This type of announcement, focusing on a specific operational or technological development rather than routine financial results (ER/IR) or mandatory regulatory disclosures (10-K/DEF 14A), fits best under a general announcement category. Since it is not a formal earnings release, a capital change, a management change, or a specific legal/governance filing, and it is a significant, non-routine update, it is classified as a general Regulatory Filing (RNS) as a catch-all for important, non-standard corporate news, although it shares characteristics with an Investor Presentation (IP) or Management Report (MDA) in content, RNS is the most appropriate fallback for a press release detailing a specific operational milestone not covered by other codes.
2014-11-26 French
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Report Publication Announcement Classification · 98% confidence The document is titled "Global Bioenergies : publication du document de référence" (publication of the reference document). It explicitly states that the company announces the publication of its 'document de référence' (reference document) for the period ending December 31, 2013, which includes annual and semi-annual accounts, and that it was filed with the AMF (Autorité des Marchés Financiers). The document itself is very short (1988 characters) and primarily serves to announce that the main report is available elsewhere ('disponible sur le site de [l'AMF] et sur le site de [Global Bioenergies]'). According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points to a Report Publication Announcement (RPA). Although the content relates to annual/interim financial data, the document's function here is the announcement itself.
2014-11-24 French
Global Bioenergies: Successful first trial in its industrial pilot
Earnings Release Classification · 99% confidence The document is a press release dated November 17, 2014, announcing a significant operational milestone: the successful first production trial of isobutene in the company's new industrial pilot plant. It details the achievement, future plans (optimization, sample production, second pilot), and includes quotes from management. This type of announcement, focusing on a specific operational or product development achievement rather than periodic financial results (like ER or IR) or mandatory regulatory filings (like 10-K), fits best under a general 'Regulatory Filing' or 'News' category. Since the definitions do not explicitly cover 'Press Release' or 'Operational Update', and it is not a formal financial report, a dividend notice, or a management change, the most appropriate fallback category is 'Regulatory Filings' (RNS), which covers general regulatory announcements and miscellaneous filings. It is not an Earnings Release (ER) as it focuses on a technical trial, not financial results. It is not an Investor Presentation (IP) as it is a news article format. It is not an RPA because it is the content of the news itself, not just an announcement that a report is available. FY 2014
2014-11-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.